Profile data is unavailable for this security.
About the company
Aqua Bio Technology ASA is a Norway-based skincare company. The Company develops and commercializes sustainable biotechnology for use in skin care products. ABT develops new active ingredients for skincare based on marine technology with documented positive effects on human skin. The ingredients are based on natural and sustainable substances, found in plants, algae and in the oceans and provide the cosmetics industry with natural alternatives to traditional ingredients. In addition to ingredients from its own technology, ABT also markets and distributes natural skincare products to consumers, retailers and professional users in Europe and the Middle East. The ABT portfolio of skincare products contains exclusive and high-end products as well as off the shelf products. They are distributed over the Internet, in stores and through professional channels such as skincare clinics.
- Revenue in NOK (TTM)13.51m
- Net income in NOK-1.50m
- Incorporated2004
- Employees2.00
- LocationAqua Bio Technology ASAFornebuveien 37LYSAKER 1366NorwayNOR
- Phone+47 98245410
- Fax+47 55328016
- Websitehttps://aquabiotechnology.com/
More ▼
Mergers & acquisitions
| Acquired company | ABTEC:OSL since announced | Transaction value |
|---|---|---|
| Ovalen As | -16.80% | 1.04m |
| Cover Brands AS | 67.06% | 1.46m |
| Skinteam Norge AS | 47.72% | 4.47m |
Data delayed at least 15 minutes, as of May 23 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Active Biotech AB publ | 0.00 | -44.69m | 182.97m | 8.00 | -- | 9.12 | -- | -- | -0.1651 | -0.1651 | 0.00 | 0.0556 | 0.00 | -- | -- | -- | -122.57 | -57.97 | -179.56 | -97.83 | -- | -- | -- | -1,454.61 | -- | -- | 0.1145 | -- | -- | -- | 21.54 | -- | -- | -- |
| AlzeCure Pharma AB | 0.00 | -37.34m | 201.62m | 11.00 | -- | 10.23 | -- | -- | -0.5685 | -0.5685 | 0.00 | 0.2122 | 0.00 | -- | -- | 0.00 | -92.80 | -52.78 | -115.25 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
| Lumito AB (publ) | 16.96k | -25.61m | 214.19m | 14.00 | -- | 2.24 | -- | 12,629.12 | -0.1244 | -0.1244 | 0.00008 | 0.4649 | 0.0001 | -- | 0.1491 | 1,133.33 | -21.11 | -20.77 | -23.47 | -22.38 | 70,276.65 | -- | -150,998.50 | -- | 0.928 | -167.26 | 0.0944 | -- | -- | -- | 4.56 | -- | -- | -- |
| Saniona AB | 16.80m | -95.58m | 215.74m | 23.00 | -- | -- | -- | 12.84 | -1.29 | -1.29 | 0.2263 | -0.2895 | 0.1546 | -- | 4.71 | 732,173.90 | -87.96 | -59.16 | -108.11 | -70.15 | -213.08 | -970.05 | -568.94 | -1,483.55 | -- | -3.18 | 1.44 | -- | 10.19 | -21.05 | 54.71 | -- | -34.94 | -- |
| Kancera AB | 0.00 | -64.74m | 216.41m | 3.00 | -- | -- | -- | -- | -0.786 | -0.786 | 0.00 | -- | -- | -- | -- | 0.00 | -- | -54.82 | -- | -66.21 | -- | -- | -- | -7,249.06 | -- | -- | -- | -- | -- | -- | -23.64 | -- | -- | -- |
| Corline Biomedical AB | 21.32m | -4.49m | 218.69m | 13.00 | -- | 2.39 | -- | 10.26 | -0.2092 | -0.2092 | 0.9944 | 4.26 | 0.2089 | -- | 6.96 | 1,643,846.00 | -4.39 | -5.71 | -4.80 | -6.24 | 115.99 | 128.60 | -21.04 | -38.46 | -- | -235.63 | 0.00 | -- | 6.28 | 74.14 | -177.67 | -- | 62.51 | -- |
| SenzaGen AB | 49.75m | -22.05m | 223.46m | 34.00 | -- | 3.31 | -- | 4.49 | -0.9136 | -0.9136 | 2.06 | 2.80 | 0.4594 | 3.04 | 4.03 | 1,466,765.00 | -20.35 | -25.84 | -27.59 | -29.85 | 70.05 | 68.62 | -44.31 | -132.29 | 1.22 | -- | 0.0242 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
| Exact Therapeutics AS | 0.00 | -48.33m | 227.77m | 8.00 | -- | 5.05 | -- | -- | -1.51 | -1.51 | 0.00 | 1.41 | 0.00 | -- | -- | -- | -67.21 | -40.21 | -86.14 | -45.67 | -- | -- | -- | -- | -- | -16,578.57 | 0.0258 | -- | -- | -- | -20.52 | -- | -- | -- |
| Aqua Bio Technology ASA | 13.51m | -1.50m | 231.39m | 2.00 | -- | 10.76 | 267.32 | 17.12 | -0.1599 | -0.1599 | 0.4938 | 0.3673 | 0.3079 | 0.6548 | 9.01 | -- | -3.42 | -80.72 | -6.75 | -125.29 | 66.69 | 5.57 | -11.12 | -965.98 | 0.1044 | 0.611 | 0.7538 | -- | 349.88 | 42.04 | 1.97 | -- | -- | -- |
| Ultimovacs ASA | 0.00 | -177.88m | 241.87m | 25.00 | -- | 0.9331 | -- | -- | -5.17 | -5.17 | 0.00 | 7.53 | 0.00 | -- | -- | 0.00 | -44.31 | -28.80 | -50.09 | -31.12 | -- | -- | -- | -- | -- | -- | 0.0136 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
| Thor Medical ASA | 0.00 | -5.56m | 242.38m | 1.00 | -- | 0.8863 | -- | -- | -0.0318 | -0.152 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -2.52 | -79.17 | -2.84 | -113.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Abliva AB | 136.68k | -95.28m | 245.44m | 6.00 | -- | 2.73 | -- | 1,795.78 | -0.0904 | -0.0904 | 0.0001 | 0.067 | 0.001 | -- | 0.0034 | -- | -70.40 | -74.59 | -80.95 | -86.98 | -14,491.24 | -- | -69,714.60 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| Arctic Bioscience AS | 33.75m | -45.51m | 251.16m | 20.00 | -- | 0.9714 | -- | 7.44 | -1.79 | -1.79 | 1.33 | 10.19 | 0.1075 | 0.7025 | 2.93 | 1,687,501.00 | -14.50 | -- | -16.61 | -- | 28.96 | -- | -134.86 | -- | 2.53 | -- | 0.0079 | -- | -1.52 | -- | -33.77 | -- | -- | -- |
| Lytix Biopharma AS | 3.99m | -87.94m | 267.90m | -- | -- | 4.27 | -- | 67.12 | -2.16 | -2.16 | 0.0981 | 1.26 | 0.037 | -- | 0.4091 | -- | -81.63 | -57.34 | -94.30 | -66.09 | -- | -- | -2,203.36 | -4,665.04 | -- | -- | -- | -- | 183.25 | 63.94 | -57.01 | -- | -- | -- |
| InDex Pharmaceuticals Holding AB | 108.08m | -56.35m | 273.16m | 7.00 | -- | 1.16 | -- | 2.53 | -0.1037 | -0.1037 | 0.2028 | 0.443 | 0.3559 | -- | -- | 15,477,000.00 | -18.55 | -37.64 | -21.24 | -41.14 | -46.98 | -450.51 | -52.13 | -454.62 | -- | -- | 0.0086 | -- | -- | 277.02 | 5.05 | -- | -- | -- |
Data as of May 23 2024. Currency figures normalised to Aqua Bio Technology ASA's reporting currency: Norwegian Krone NOK
